Results 81 to 90 of about 7,899 (110)

Molecular surveillance-informed personalized multidisciplinary therapy achieves prolonged survival in a patient with Lynch syndrome-associated colorectal cancer: A case report. [PDF]

World J Gastrointest Oncol
Xu XX, Gao YH, Du CZ, Gao XX, Chen P, Fan RF, Li HT, Qiao Z.   +7 more
europepmc   +1 more source

Colorectal adenoma recurrence: an analysis of risk factors and gut microbiota characteristics. [PDF]

BMC Gastroenterol
Chen Y, Gao X, Wang L, Zhang C, Fang Y.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.

Clinical cancer research : an official journal of the American Association for Cancer Research, 1998
p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA). We analyzed p21 expression during colorectal tumorigenesis, its association with its transcriptional regulator p53, and its relationship to rates of cell proliferation and apoptosis.
F A, Sinicrope, G, Roddey, M, Lemoine, S, Ruan, L C, Stephens, M L, Frazier, Y, Shen, W, Zhang   +7 more
openaire   +1 more source

Diagnostic Approach and Management of Lynch Syndrome (Hereditary Nonpolyposis Colorectal Carcinoma): A Guide for Clinicians

Ca-A Cancer Journal for Clinicians, 2006
H Morreau, H F A Vasen, M H Breuning
exaly